CLIENT CASE STUDIES
FUNDED GLOBAL R&D CONSORTIUM
RLS were asked by a leading Medical Imaging Software developer (who provide specialist solutions to GE, Canon and Boston Scientific) to secure funding for the implementation of an integrated radiotherapy treatment system.
We built a consortium including the leading cancer treatment centres in the Netherlands and Portugal alongside a French technology partner, developed a full R&D project strategy in collaboration with these collaborators and the client's scientific leadership and secured funding of over £1m to deliver this programme of work from highly-competitive EU and UK public-sector funding matched by venture capital and private equity investors.
TRANSLATIONAL RESEARCH CLINICAL TRIAL APPROVAL
RLS were approached by a clinical academic team representing three leading UK research universities and asked to support the translation of research into a new machine-learning based invasive diagnostic from a laboratory setting into first-in-human clinical trials.
​
We combined a practical approach to compiling the necessary technical and safety data needed for ethics approval with a forward-looking coaching approach to empower the project team to progress the project to market via robust yet pragmatic design control and risk management tools. Clinical trial approval was obtained ahead of schedule from the UK Medicines and Healthcare Products regulatory Agency (MHRA).
AI SOFTWARE REGULATORY/ LAUNCH STRATEGY
Our client, a successful manufacturer of wellness products including artificial intelligence software to assist physiotherapists, approached RLS to ask for help defining the steps needed validate their product for use in clinical settings and access a £1.5bn UK market.
​
We assessed the existing evidence including information security compliance, engaged with NHS key opinion leading clinicians and patient representatives, and produced a go-to-market plan to rapidly address this commercial opportunity all linked to timely and relevant clinical evidence. Subsequently funding was awarded by the National Institute of Health Research.
​
​
PHARMA PATIENT ENGAGEMENT
RLS were engaged by the European and North American Patient Engagement teams from a top-5 global pharmaceutical manufacturer to provide expertise on the use of Artificial Intelligence to augment healthcare professionals and to provide new opportunities to improve access to medicines.
​
We worked closely with Partnerships, Product Development and Therapeutic Area as well as patient representatives to create and deliver content on the topic to a general audience as part of a major international online and in-person conference.